Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 196,496,400
  • Shares Outstanding, K 1,734,455
  • Annual Sales, $ 40,109 M
  • Annual Income, $ 5,723 M
  • EBIT $ 8,588 M
  • EBITDA $ 11,831 M
  • 60-Month Beta 0.73
  • Price/Sales 4.87
  • Price/Cash Flow 17.70
  • Price/Book 4.88

Options Overview Details

View History
  • Implied Volatility 21.75% ( +1.23%)
  • Historical Volatility 11.86%
  • IV Percentile 71%
  • IV Rank 49.98%
  • IV High 29.56% on 10/08/24
  • IV Low 13.95% on 11/27/24
  • Put/Call Vol Ratio 0.74
  • Today's Volume 10,928
  • Volume Avg (30-Day) 7,148
  • Put/Call OI Ratio 0.91
  • Today's Open Interest 217,920
  • Open Int (30-Day) 202,654

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.34
  • Number of Estimates 9
  • High Estimate 1.34
  • Low Estimate 1.33
  • Prior Year 1.19
  • Growth Rate Est. (year over year) +12.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
111.85 +0.07%
on 12/18/24
120.53 -7.14%
on 11/27/24
-5.43 (-4.63%)
since 11/18/24
3-Month
111.68 +0.22%
on 10/04/24
121.00 -7.50%
on 11/06/24
-2.95 (-2.57%)
since 09/18/24
52-Week
99.71 +12.26%
on 07/18/24
121.64 -7.98%
on 03/08/24
+3.87 (+3.58%)
since 12/18/23

Most Recent Stories

More News
BSX Trades Near 52-Week High: Does the Stock Hold More Potential?

Boston Scientific Corporation BSX remains in the spotlight, with its stock currently trading close to its 52-week high. In the past six trading sessions, the stock has consistently traded above $90.00...

ABT : 111.93 (-1.20%)
BSX : 88.03 (-2.65%)
MDT : 80.03 (-1.65%)
The Smartest Dividend Stocks to Buy With $500 Right Now

As an investor, your goal is to select quality stocks that will advance over a period of years -- but this doesn't mean you have to wait a long time for all of the rewards. If you add a few dividend stocks...

ABT : 111.93 (-1.20%)
KO : 62.85 (-0.87%)
JNJ : 144.75 (-1.13%)
Abbott's FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in Alberta

/CNW/ -- Abbott (NYSE: ABT) today announced that the Government of Alberta has added Abbott's FreeStyle Libre 2* flash glucose monitoring system to the Alberta...

ABT : 111.93 (-1.20%)
How Abbott Labs Became a Dividend Growth Investor's Dream

Abbott Laboratories is one of the best dividend stocks to buy today: here's why.

ABT : 111.93 (-1.20%)
Is Medtronic Stock Underperforming the S&P 500?

Although Medtronic has lagged behind the broader S&P 500 index over the past three months, analysts remain moderately optimistic about the stock’s prospects.

ABT : 111.93 (-1.20%)
$SPX : 5,872.16 (-2.95%)
MDT : 80.03 (-1.65%)
Is Abbott Laboratories Stock Underperforming the Nasdaq?

Despite Abbott Laboratories’ underperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain bullish about the stock’s prospects.

ABT : 111.93 (-1.20%)
$NASX : 19,392.69 (-3.56%)
JNJ : 144.75 (-1.13%)
Top Research Reports for Abbott, BlackRock & ConocoPhillips

Wednesday, November 27, 2024The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories...

BLK : 1,020.30 (-2.76%)
ABT : 111.93 (-1.20%)
TTE : 53.68 (-1.05%)
COP : 95.85 (-2.45%)
ITW : 261.23 (-2.48%)
PM : 124.55 (-1.18%)
2 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income

Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical industry. From the end of 2022 through Nov. 22, the benchmark S&P 500 index rose...

ABT : 111.93 (-1.20%)
ABBV : 173.02 (-1.35%)
PFE : 25.89 (-2.04%)
2 Dividend Kings to Buy for a Lifetime of Passive Income

Dividend Kings are among the best income stocks on the market. Any corporation capable of raising its payouts for 50 consecutive years -- the requirement to become a Dividend King -- has an incredibly...

ABT : 111.93 (-1.20%)
KO : 62.85 (-0.87%)
Five Top Heart Health Stocks to Buy Heading into 2025

Heart health statistics are startling. Not only is heart disease the leading cause of death in the United States, it also claims the life of one person every 33 seconds. Plus, the estimated global annual...

ABT : 111.93 (-1.20%)
BSX : 88.03 (-2.65%)
CRDL : 1.3400 (-2.19%)
GILD : 90.69 (-2.27%)
MDT : 80.03 (-1.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 115.74
2nd Resistance Point 114.94
1st Resistance Point 113.44
Last Price 111.93
1st Support Level 111.14
2nd Support Level 110.34
3rd Support Level 108.84

See More

52-Week High 121.64
Fibonacci 61.8% 113.26
Last Price 111.93
Fibonacci 50% 110.68
Fibonacci 38.2% 108.09
52-Week Low 99.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar